Al-Modawat Specialized Medical Company (TADAWUL:9594)
Saudi Arabia
· Delayed Price · Currency is SAR
3.150
-0.209 (-6.23%)
At close: Mar 9, 2026
TADAWUL:9594 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Revenue | 121.82 | 75.49 | 74.31 | 58.57 | 40.84 |
| Revenue Growth (YoY) | 61.38% | 1.59% | 26.88% | 43.41% | - |
| Cost of Revenue | - | 45.09 | 33.93 | 30.71 | 26.17 |
| Gross Profit | 121.82 | 30.4 | 40.37 | 27.85 | 14.67 |
| Selling, General & Admin | - | 19.39 | 15.67 | 14.13 | 15.56 |
| Other Operating Expenses | 101.54 | - | - | - | -0.42 |
| Operating Expenses | 101.54 | 22.4 | 18.5 | 15.71 | 15.14 |
| Operating Income | 20.28 | 8 | 21.88 | 12.14 | -0.48 |
| Interest Expense | - | -1.13 | -1.13 | -0.69 | -0.22 |
| Other Non Operating Income (Expenses) | -0 | 0.03 | 0.04 | -0.52 | - |
| EBT Excluding Unusual Items | 20.28 | 6.9 | 20.78 | 10.92 | -0.69 |
| Other Unusual Items | - | -0.11 | -1.33 | -0.31 | - |
| Pretax Income | 20.28 | 6.79 | 19.45 | 10.61 | -0.69 |
| Income Tax Expense | 1.31 | 0.72 | 0.85 | 0.33 | 0.03 |
| Earnings From Continuing Operations | 18.98 | 6.07 | 18.59 | 10.28 | -0.73 |
| Net Income | 18.98 | 6.07 | 18.59 | 10.31 | -2.21 |
| Net Income to Common | 18.98 | 6.07 | 18.59 | 10.31 | -2.21 |
| Net Income Growth | 212.44% | -67.33% | 80.28% | - | - |
| Shares Outstanding (Basic) | 70 | 69 | 57 | 57 | - |
| Shares Outstanding (Diluted) | 70 | 69 | 57 | 57 | - |
| Shares Change (YoY) | 1.42% | 21.57% | - | - | - |
| EPS (Basic) | 0.27 | 0.09 | 0.33 | 0.18 | - |
| EPS (Diluted) | 0.27 | 0.09 | 0.33 | 0.18 | - |
| EPS Growth | 208.08% | -73.13% | 80.28% | - | - |
| Free Cash Flow | 4.28 | -8.52 | 9.68 | 2.32 | -2.26 |
| Free Cash Flow Per Share | 0.06 | -0.12 | 0.17 | 0.04 | - |
| Dividend Per Share | - | - | 0.233 | - | - |
| Gross Margin | 100.00% | 40.27% | 54.33% | 47.56% | 35.92% |
| Operating Margin | 16.65% | 10.60% | 29.44% | 20.73% | -1.17% |
| Profit Margin | 15.58% | 8.04% | 25.02% | 17.61% | -5.40% |
| Free Cash Flow Margin | 3.51% | -11.29% | 13.03% | 3.96% | -5.53% |
| EBITDA | 23.91 | 10.34 | 23.62 | 13.69 | 0.93 |
| EBITDA Margin | 19.63% | 13.69% | 31.79% | 23.37% | 2.29% |
| D&A For EBITDA | 3.63 | 2.34 | 1.74 | 1.55 | 1.41 |
| EBIT | 20.28 | 8 | 21.88 | 12.14 | -0.48 |
| EBIT Margin | 16.65% | 10.60% | 29.44% | 20.73% | -1.17% |
| Effective Tax Rate | 6.44% | 10.56% | 4.39% | 3.09% | - |
| Advertising Expenses | - | 0.97 | 0.16 | 0.08 | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.